Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chaparral AER Data Resembles Kava Reports, CRN’s Cardellina Says

This article was originally published in The Tan Sheet

Executive Summary

Adverse event reports on chaparral have certain parallels with those that have been filed for kava, according to Council for Responsible Nutrition VP-Botanical Science & Regulatory Affairs John Cardellina, PhD
Advertisement

Related Content

Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN
Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN
Melatonin, Chromium Monograph Human Safety Data Should Be Used – CRN
IoM Supplement Safety Plan’s Reliance On AER Reviews Problematic – CRN
IoM Supplement Safety Plan’s Reliance On AER Reviews Problematic – CRN
Shark cartilage monograph
Three-Step Supplement Safety Review Model Proposed by IoM
Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory
USP Negative Ephedra Monograph To Follow FDA Final Action
USP Negative Ephedra Monograph To Follow FDA Final Action

Topics

Advertisement
UsernamePublicRestriction

Register

PS094496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel